Conmed (CNMD) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.00% |
| Dec 31, 2025 | 7.82% |
| Sep 30, 2025 | 8.10% |
| Jun 30, 2025 | 8.24% |
| Mar 31, 2025 | 6.86% |
| Dec 31, 2024 | 6.26% |
| Sep 30, 2024 | 5.88% |
| Jun 30, 2024 | 4.82% |
| Mar 31, 2024 | 4.28% |
| Dec 31, 2023 | 4.72% |
| Sep 30, 2023 | 4.06% |
| Jun 30, 2023 | 3.78% |
| Mar 31, 2023 | 3.21% |
| Dec 31, 2022 | 3.38% |
| Sep 30, 2022 | 3.97% |
| Jun 30, 2022 | 2.93% |
| Mar 31, 2022 | 6.53% |
| Dec 31, 2021 | 6.23% |
| Sep 30, 2021 | 5.28% |
| Jun 30, 2021 | 5.13% |
| Mar 31, 2021 | 4.50% |
| Dec 31, 2020 | 3.92% |
| Sep 30, 2020 | 3.42% |
| Jun 30, 2020 | 3.14% |
| Mar 31, 2020 | 4.09% |
| Dec 31, 2019 | 4.09% |
| Sep 30, 2019 | 3.41% |
| Jun 30, 2019 | 2.97% |
| Mar 31, 2019 | 3.08% |
| Dec 31, 2018 | 1.78% |
| Sep 30, 2018 | 1.96% |
| Jun 30, 2018 | 2.08% |
| Mar 31, 2018 | 1.46% |
| Dec 31, 2017 | 0.79% |
| Sep 30, 2017 | -0.43% |
| Jun 30, 2017 | -0.37% |
| Mar 31, 2017 | -0.38% |
| Dec 31, 2016 | 0.26% |
| Sep 30, 2016 | -0.85% |
| Jun 30, 2016 | -1.23% |
| Dec 31, 2015 | -0.05% |